Barrington Research Has Lowered Expectations for Concentrix (NASDAQ:CNXC) Stock Price

Concentrix (NASDAQ:CNXC) had its price objective lowered by analysts at Barrington Research from $62.00 to $38.00 in a research note issued on Wednesday,Benzinga reports. The firm currently has an “outperform” rating on the stock. Barrington Research’s price objective would suggest a potential upside of 37.09% from the company’s previous close.

A number of other equities research analysts also recently issued reports on CNXC. Wall Street Zen upgraded shares of Concentrix from a “hold” rating to a “buy” rating in a research report on Saturday, February 14th. Canaccord Genuity Group lowered their price target on shares of Concentrix from $80.00 to $55.00 and set a “buy” rating on the stock in a report on Wednesday. Robert W. Baird cut their price objective on Concentrix from $52.00 to $40.00 and set an “outperform” rating for the company in a report on Wednesday. Finally, Weiss Ratings cut Concentrix from a “hold (c-)” rating to a “sell (d)” rating in a research report on Thursday, January 29th. Three equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Concentrix currently has an average rating of “Hold” and a consensus price target of $48.50.

Concentrix Trading Up 12.4%

NASDAQ:CNXC opened at $27.72 on Wednesday. The stock has a market cap of $1.70 billion, a PE ratio of -1.29, a price-to-earnings-growth ratio of 0.26 and a beta of 0.50. Concentrix has a fifty-two week low of $24.27 and a fifty-two week high of $66.00. The company has a debt-to-equity ratio of 1.43, a current ratio of 1.18 and a quick ratio of 1.40. The stock’s 50-day moving average is $34.72 and its two-hundred day moving average is $40.14.

Concentrix (NASDAQ:CNXC) last posted its quarterly earnings results on Tuesday, March 24th. The company reported $2.61 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.65 by ($0.04). The company had revenue of $2.50 billion during the quarter, compared to analysts’ expectations of $2.49 billion. Concentrix had a positive return on equity of 17.80% and a negative net margin of 13.35%.Concentrix’s revenue for the quarter was up 5.4% compared to the same quarter last year. During the same period last year, the company earned $2.79 earnings per share. As a group, equities research analysts forecast that Concentrix will post 10.11 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Concentrix news, CEO Christopher A. Caldwell bought 1,000 shares of the firm’s stock in a transaction on Thursday, January 29th. The stock was bought at an average cost of $37.07 per share, with a total value of $37,070.00. Following the completion of the transaction, the chief executive officer directly owned 362,075 shares of the company’s stock, valued at approximately $13,422,120.25. The trade was a 0.28% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 0.90% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Concentrix

Several institutional investors and hedge funds have recently modified their holdings of the business. Osaic Holdings Inc. grew its position in shares of Concentrix by 13.4% in the second quarter. Osaic Holdings Inc. now owns 2,222 shares of the company’s stock valued at $118,000 after purchasing an additional 263 shares during the last quarter. State of Wyoming lifted its position in shares of Concentrix by 6.2% during the 4th quarter. State of Wyoming now owns 5,029 shares of the company’s stock worth $209,000 after purchasing an additional 293 shares during the last quarter. Deutsche Bank AG lifted its position in shares of Concentrix by 4.7% during the 4th quarter. Deutsche Bank AG now owns 6,767 shares of the company’s stock worth $281,000 after purchasing an additional 303 shares during the last quarter. Clearstead Advisors LLC boosted its stake in Concentrix by 26.4% during the 3rd quarter. Clearstead Advisors LLC now owns 1,650 shares of the company’s stock valued at $76,000 after purchasing an additional 345 shares during the period. Finally, Brevan Howard Capital Management LP boosted its stake in Concentrix by 4.5% during the 2nd quarter. Brevan Howard Capital Management LP now owns 8,951 shares of the company’s stock valued at $473,000 after purchasing an additional 384 shares during the period. Institutional investors and hedge funds own 90.34% of the company’s stock.

Trending Headlines about Concentrix

Here are the key news stories impacting Concentrix this week:

• Positive Sentiment: Several firms cut targets but kept constructive ratings — Canaccord cut its target to $55 and kept a Buy rating, Barrington cut to $38 but stayed Outperform, and Robert W. Baird trimmed to $40 while maintaining Outperform — signaling analysts still see upside versus the current price. Article Title
• Positive Sentiment: Some analysts continue to view CNXC as undervalued on a forward P/E basis and as a potential rebound candidate if margins and cash flow recover in H2 2026. Article Title
• Neutral Sentiment: Company revenue modestly beat estimates ($2.50B vs ~$2.49B), showing continued top-line growth even as profitability slipped. Earnings/Stats
• Neutral Sentiment: Macro/market coverage: Bloomberg flagged CNXC among “stock movers,” reflecting the heavy trading and news-driven volatility rather than a single structural change. Stock Movers
• Negative Sentiment: Margin squeeze and cautious 2026 guidance triggered a large selloff — investors reacted to lower margin outlook and conservative revenue/cash-flow assumptions. Yahoo Finance
• Negative Sentiment: Analyst and investor skepticism: Seeking Alpha pieces highlight execution risk from an expensive transition to AI-driven services, negative Q1 free cash flow, high leverage and a downgraded stance that argues CNXC is “cheap for a reason.” SA Downgrade
• Negative Sentiment: Investor caution pieces reinforce the risks — another Seeking Alpha article explains why some investors are avoiding CNXC despite low valuation multiples. SA Opinion
• Negative Sentiment: Price action: coverage noted CNXC hit a new 1‑year low after the earnings miss, underscoring near-term downside pressure until margins and cash flow show clear improvement. 1-Year Low

About Concentrix

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.